NCT00421187View on ClinicalTrials.gov

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

PHASE4TerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

May 31, 2008

Conditions

Febrile Neutropenia

Interventions

DRUG

Liposomal amphotericin B (AmBisome®)

DRUG

Liposomal amphotericin B (AmBisome®)

Trial Locations (1)

167 77

Gilead Sciences, Athens

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY